CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities
Net income	$ 9,997	$ 11,197
Adjustments to reconcile net income to net cash provided by operating activities
Provision for loan losses	10,100	1,325
Depreciation and amortization	1,185	1,215
Net losses (gains) on the sale of OREO	7	(188)
Gains on sales of investment securities	(670)	0
Unrealized gains on equity securities	(115)	(156)
Gain on sale of assets	(6)	0
Net amortization of premium/discount on investment securities	70	(87)
Net accretion of merger accounting adjustments	(509)	(624)
Amortization of core deposit intangible	452	525
Amortization of right of use asset	377	0
Net change in right of use assets and lease liabilities	(302)	86
Increase in OREO valuation allowance	2,177	766
Increase in cash surrender value of bank owned life insurance	(661)	(662)
Increase in deferred income tax benefit	(2,253)	(639)
Increase in accrued interest receivable	(3,956)	(256)
Stock based compensation	262	232
Net change due to deficit of fair market value over cost of leveraged ESOP shares released	(37)	(4)
Decrease (increase) in net deferred loan costs	3,542	(508)
Increase (decrease) in accrued expenses and other liabilities	1,236	(311)
(Increase) decrease in other assets	(917)	180
Net Cash Provided by Operating Activities	19,979	12,091
Cash Flows from Investing Activities
Purchase of AFS investment securities	(107,351)	(18,133)
Proceeds from redemption or principal payments of AFS investment securities	26,731	11,862
Purchase of HTM investment securities	0	(9,982)
Proceeds from maturities or principal payments of HTM investment securities	0	17,479
Proceeds from sale of AFS investment securities	64,109	0
Net decrease (increase) of FHLB stock	32	(689)
Loans originated or acquired	(497,153)	(346,818)
Principal collected on loans	320,765	274,912
Purchase of premises and equipment	(209)	(613)
Proceeds from sale of OREO	2,831	324
Proceeds from disposal of asset	21	0
Net Cash Used in Investing Activities	(190,224)	(71,658)
Net Cash Used in Investing Activities
Net increase in deposits	267,769	130,331
Proceeds from long-term debt	164,036	35,000
Payments of long-term debt	(76,194)	(49)
Net decrease in short term borrowings	(5,000)	(20,000)
Payments of subordinated notes	(23,000)	0
Dividends paid	(2,115)	(2,004)
Net change in unearned ESOP shares	0	(39)
Repurchase of common stock	(27)	(17)
Net Cash Provided by Financing Activities	325,469	143,222
Increase in Cash and Cash Equivalents	155,224	83,655
Cash and Cash Equivalents - January 1	32,469	33,036
Cash and Cash Equivalents - September 30	187,693	116,691
Cash paid during the period for
Interest	9,072	14,579
Income taxes	7,133	4,913
Supplemental Schedule of Non-Cash Operating Activities
Issuance of common stock for payment of compensation	303	107
Transfer from loans to OREO	1,240	3,266
Financed amount of sale of OREO	0	280
Supplemental Schedule of Non-Cash Investing and Financing Activities
Right-of use assets and lease liability recorded upon adoption of ASC 842	$ 0	$ 8,933